Potential Role and Clinical Value of PPP2CA in Hepatocellular Carcinoma

• Published in: Journal of clinical and translational hepatology Vol. 9; no. 5; pp. 661 - 671
• Main Authors: Yang, Cheng-Lei, Qiu, Xue, Lin, Jin-Yan, Chen, Xiao-Yu, Zhang, Yu-Mei, Hu, Xiao-Yin, Zhong, Jian-Hong, Tang, Shen, Li, Xi-Yi, Xiang, Bang-De, Zhang, Zhi-Ming
• Format: Journal Article
• Language: English
• Published: China XIA & HE Publishing Inc 28.10.2021
• Subjects: Original; Diagnostic marker; PPP2CA; Hepatocellular carcinoma; Molecular mechanism
• ISSN: 2225-0719; 2310-8819
• DOI: 10.14218/JCTH.2020.00168

Protein phosphatase 2A (PP2A) is associated with many cancers. This study aimed to clarify whether PPP2CA, which encodes the alpha isoform of the catalytic subunit of PP2A, plays a role in hepatocellular carcinoma (HCC) and to identify the potential underlying molecular pathways. Based on bioinformatics, public databases and our in-house RNA-Seq database, we analyzed the clinical value and molecular mechanism of PPP2CA in HCC. Data were analyzed from 2,545 patients with HCC and 1,993 controls without HCC indexed in The Cancer Genome Atlas database, the Gene Expression Omnibus database and our in-house RNA-Seq database. PPP2CA expression was significantly higher in HCC tissue than in non-cancerous tissues (standardized mean difference: 0.69, 95% confidence interval [CI]: 0.50-0.89). PPP2CA expression was able to differentiate HCC from non-HCC, with an area under the summary receiver operator characteristic curve of 0.79 (95% CI: 0.75-0.83). Immunohistochemistry of tissue sections confirmed that PPP2CA protein was up-regulated in HCC tissues. High PPP2CA expression in HCC patients was associated with shorter overall, progression-free and disease-free survival. Potential molecular pathways through which PPP2CA may be involved in HCC were determined using miRWalk 2.0 as well as analysis of Gene Ontology categories, Kyoto Encyclopedia of Genes and Genomes pathways, and protein-protein interaction networks. PPP2CA is up-regulated in HCC and higher expression correlates with worse prognosis. PPP2CA shows potential as a diagnostic marker for HCC. Future studies should examine whether PPP2CA contributes to HCC through the candidate microRNAs, pathways and hub genes identified in this study.